Skip to main content
Caplight Logo









Beijing Echo Biotech Co., Ltd.

Beijing Echo Biotech Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://echobiotech.com/

Last Round

Series B

Nov 6, 2025

Total Funding Raised

$38.71M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Beijing Echo Biotech Co., Ltd. is a biotechnology company that provides exosome-related research services, GMP-grade exosome raw materials, and engineered exosome technology platforms for regenerative medicine and disease treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Data as a Service

AI Layer

Non-AI

Keywords

exosome researchextracellular vesicleEVcontract development and manufacturing organizationCDMOregenerative medicineexosome manufacturingcontract research organizationCROmulti-omicsGMP manufacturingexosome purificationtranslational medicinebiotech servicescell therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beijing Echo Biotech Co., Ltd. Comparables

Compare Beijing Echo Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Echo Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carrier Biomed (Suzhou) Co., Ltd.
85%
EXO Biologics
80%
CellBio Scientific
77%

Beijing Echo Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 6, 2025
Series A ExtensionMar 3, 2023
Series A ExtensionJan 11, 2022
Series AJul 30, 2021
Pre SeedMar 25, 2019

Key People

Founding team and executive leadership

Guanyi Kong

CEO

Executive Team

Beijing Echo Biotech Co., Ltd. Investors

Notable investors and investment history

Beijing Echo Biotech Co., Ltd. investors
InvestorRounds
Zhongbo JuliSeries A Extension, Series B
Baidu VenturesSeries A Extension
Ennovation VenturesPre Seed
Volcanics VentureSeries A, Series A Extension
Beihang Investment Co., Ltd.Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    Grew 71% QoQ, from 7 to 12 employees.

  • Nov 6, 2025

    $13.4M round led by Zhongbo Juli

Beijing Echo Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Beijing Echo Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beijing Echo Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range12
Year FoundedN/A
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?